Hua X, Bi XW, Zhao JL, Shi YX, et al. Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Metastatic Breast Cancer with Hormone Receptor-positive and HER2-positive (SYSUCC-002). Clin Cancer Res 2021 Nov 22. pii: 1078-0432.CCR-21-3435.
PMID: 34810217